The Duloxetine Delayed-Release Capsules' voluntary recall began on Oct. 10 after the FDA deemed the medication the ...
A Duloxetine recall by the FDA has flagged more than 7,100 bottles of the Cymbalta generic drug due to a cancerous chemical.
Some bottles of the antidepressant duloxetine, sold under the brand name Cymbalta, were recalled due to the presence of a ...
Thousands of bottles of a commonly prescribed antidepressant drug have been recalled by the FDA because they were found to ...
The recall was initiated due to the discovery of N-nitroso-duloxetine, a chemical impurity classified as a nitrosamine.
The Food and Drug Administration (FDA) issued a Class II recall of more than 7,100 bottles of the antidepressant duloxetine ...
The FDA has recalled thousands of bottles of the antidepressant duloxetine, sold under brand name Cymbalta, due to the ...
Thousands of bottles of a popular antidepressant medication are being recalled due to the presence of what the National ...
Over 7,000 bottles of the antidepressant medication duloxetine, sold under the brand name Cymbalta, have been recalled, the ...
The FDA is recalling more than 7,000 bottles of the antidepressant duloxetine due to a possible cancer-causing chemical.
The FDA's recall involves 7,107 bottles containing 500 delayed-release 20 milligram duloxetine capsules, which are prescribed to treat conditions such as anxiety, depression, nerve pain related to ...
The U.S. Food and Drug Administration has recalled thousands of bottles of the antidepressant duloxetine over the presence of ...